Recombinant Proteins from CalAsia Pharmaceuticals 
CalAsia Pharmaceuticals, Inc. is an employee owned early stage pharmaceutical company focused on the rapid discovery of drug-like small molecules by utilizing its core technologies.
CalAsia produces bulk quantities of highly-purified protein drug targets suitable X-ray crystallographic studies, biochemical assays, and immunochemistry. These proteins are available now for discounted purchase by the drug-discovery community through KeraFAST.
Products:
Branched Chain Amino-acid Transaminase-2 (BCAT2); Full-length Human
FK506 Binding Protein-12 (FKBP12, FKBP1A), human recombinant
Fructose 1,6-bisphosphatase (FBPase); Full-length Human
Liver glucokinase (GK); Full-length Human
Pancreatic glucokinase (GK); Full-length Human
TNF receptor associated protein-1 (TRAP1); Full-length Human
